Skip to main content
. 2018 Feb 27;16(2):e05182. doi: 10.2903/j.efsa.2018.5182

Table 1.

Summary of presumptive ESBL‐ and AmpC‐producing Salmonella spp. isolates from meat from broilers, broilers, meat from turkeys, fattening turkeys and laying hens collected within the routine monitoring in 2016

Matrix Presumptive ESBL and/or AmpC producersa n (%R) Presumptive ESBL producersb n (%R) Presumptive AmpC producersc n (%R) Presumptive ESBL+AmpC producers n (%R) Presumptive CP n (%R)
Humans (N = 8,746, 13 MSs) 76 (0.9) 70 (0.8) 5 (0.1) 0 (< 0.01) 0 (< 0.01)
Meat from broilers (N = 763, 19 MSs) 19 (2.5) 16 (2.1) 5 (0.7) 2 (0.6) 0 (< 0.48)
Broilers (N = 1,717, 22 MSs) 14 (0.8) 11 (0.6) 3 (0.2) 0 (< 0.21) 0 (< 0.21)
Meat from turkeys (N = 295, 8 MSs) 3 (1.0) 3 (1.0) 1 (0.3) 1 (0.3) 0 (< 1.3)
Fattening turkeys (N = 663, 11 MSs) 6 (0.9) 6 (0.9) 0 (< 0.6) 0 (< 0.6) 0 (< 0.6)
Laying hens (N = 1,216, 22 MSs) 1 (0.1) 1 (0.1) 0 (< 0.3) 0 (< 0.3) 0 (< 0.3)

N: Total number of isolates reported for this monitoring by the MSs; n: number of the isolates resistant; % R: percentage of resistant isolates; ESBL: extended‐spectrum β‐lactamase; MS: Member States; CP: carbapenemase producers.

a

Isolates exhibiting only ESBL‐ and/or only AmpC‐ and/or ESBL+AmpC phenotype.

b

Isolates exhibiting an ESBL‐ and ESBL+AmpC phenotype.

c

Isolates exhibiting an AmpC‐ and ESBL+AmpC phenotype.